Glasgow HIV Congress (2022)
1 February 2023. Related: Conference reports.
HIV 16 Glasgow 2022
Glasgow 2022: pipeline studies with bNAbs N6LS and maturation inhibitor GSK254
1 February 2023. Related: Conference reports, Antiretrovirals.
Glasgow 2022: doravirine updates
1 February 2023. Related: Conference reports, Antiretrovirals.
Glasgow 2022: long-acting cabotegravir/rilpivirine: adverse events, implementation and PROMs
1 February 2023. Related: Conference reports, Antiretrovirals.
Glasgow HIV Congress 2022
1 December 2022. Related: Conference reports.
Glasgow 2022: Better re-suppression after viral rebound with DTG-based ART compared to EFV- or PI-based regimens
1 December 2022. Related: Conference reports, Treatment strategies.
Glasgow 2022: Vertical transmission rate below 0.3% among women living with HIV in the UK
1 December 2022. Related: Conference reports, Pregnancy.